Physician profile
John Edmonds
NPI 1164432993
$2,392.91
in general payments reported to CMS, 2019-2025
21 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $124 · 2021: $98.33 · 2022: $311 · 2023: $221 · 2024: $487 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $646.27 | 2019-2025 | Clareon, Tryptyr, Centurion |
| Allergan, INC. | $179.27 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $176.71 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $173.39 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $151.03 | 2019-2024 | Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $150.01 | 2021-2024 | Cequa |
| Rxsight INC | $137.79 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Shire North American Group INC | $137.07 | 2019 | |
| Ocular Therapeutix, INC. | $108.89 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $102.35 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $70.36 | 2022-2024 | Vyzulta, Xiidra, Lotemax Sm |
| Carl Zeiss Meditec, INC. | $60.00 | 2022 | |
| Oyster Point Pharma, INC. | $59.47 | 2023 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $52.99 | 2019 | |
| Abbvie INC. | $41.00 | 2022-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oasis Medical, INC. | $39.10 | 2019 | |
| Rayner Intraocular Lenses Limited | $37.91 | 2025 | Rayone Spheric, Rayner Cataract Set 1, Rayone Emv |
| Apellis Pharmaceuticals, INC. | $21.58 | 2024 | Syfovre |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Omeros Corporation | $14.19 | 2019 | |
| Eyevance Pharmaceuticals LLC | $14.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Edmonds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.